BRIEF-Regeneron Pharmaceuticals reports preliminary Q4 U.S. net sales of eylea injection of $858 mln
Jan 9 Regeneron Pharmaceuticals Inc -
* Preliminary U.S. net sales of eylea injection of $858 million for Q4 2016
* Preliminary global sales of eylea of more than $5 billion for full year 2016 - sec filing Source text: (bit.ly/2jbjMat) Further company coverage:
Buffett's Berkshire says quarterly profit rises 15 pct
Feb 25 Warren Buffett's Berkshire Hathaway Inc on Saturday said fourth-quarter profit rose 15 percent from a year earlier, helped by gains from investments and derivatives.